[Expression of recombinant human hemangiopoietin and preparation of its polyclonal antibody].

Qian Ren(Nanjing University of Information Science and Technology), Zhongchao Han(Amgen (United States)), Zhong Chen(Sun Yat-sen University), Yong-Jun Liu(Tobacco Research Institute), Fengxia Ma(University of California, Irvine), Bin Xu(Nanjing University of Chinese Medicine), Zhibo Han(Amgen (United States)), Shihong Lu(Chinese Academy of Medical Sciences & Peking Union Medical College)
PubMed
November 1, 2006
Cited by 0

Related Papers

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
|The Journal of Experimental Medicine|2000|837
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
|Cellular and Molecular Bioengineering|2016|524
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
|PubMed|2001|479
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
|Nature Genetics|2015|400